These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 36193976)
21. [The immune-modulation therapy of autoimmune liver diseases]. Lian M; Ma X Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):622-624. PubMed ID: 34371531 [TBL] [Abstract][Full Text] [Related]
22. The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective. Wang L; Cao ZM; Zhang LL; Li JM; Lv WL Front Immunol; 2022; 13():923599. PubMed ID: 35911738 [TBL] [Abstract][Full Text] [Related]
23. Gut and oral microbiota in autoimmune liver disease. Abe K; Fujita M; Hayashi M; Okai K; Takahashi A; Ohira H Fukushima J Med Sci; 2020 Jan; 65(3):71-75. PubMed ID: 31564673 [TBL] [Abstract][Full Text] [Related]
24. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037 [TBL] [Abstract][Full Text] [Related]
25. Liver-Microbiome Axis in Health and Disease. Adolph TE; Grander C; Moschen AR; Tilg H Trends Immunol; 2018 Sep; 39(9):712-723. PubMed ID: 29843959 [TBL] [Abstract][Full Text] [Related]
26. Gut microbiome and liver diseases. Tilg H; Cani PD; Mayer EA Gut; 2016 Dec; 65(12):2035-2044. PubMed ID: 27802157 [TBL] [Abstract][Full Text] [Related]
30. Tumour necrosis factor alpha (TNF-α) genetic polymorphisms and the risk of autoimmune liver disease: a meta-analysis. Li S; Huang X; Zhong H; Chen Z; Peng Q; Deng Y; Qin X J Genet; 2013 Dec; 92(3):617-28. PubMed ID: 24371186 [TBL] [Abstract][Full Text] [Related]
31. Gut microbiota translocation promotes autoimmune cholangitis. Ma HD; Zhao ZB; Ma WT; Liu QZ; Gao CY; Li L; Wang J; Tsuneyama K; Liu B; Zhang W; Zhou Y; Gershwin ME; Lian ZX J Autoimmun; 2018 Dec; 95():47-57. PubMed ID: 30340822 [TBL] [Abstract][Full Text] [Related]
32. Differences in Gut Microbiome Profile between Healthy Children and Children with Inflammatory Bowel Disease and/or Autoimmune Liver Disease: A Case-Control Study. Lopez RN; Leach ST; Bowcock N; Coker E; Shapiro AJ; Day AS; Lemberg DA Pathogens; 2023 Apr; 12(4):. PubMed ID: 37111471 [TBL] [Abstract][Full Text] [Related]
33. [Histopathological features and pathological diagnosis of IgG4-related hepatobiliary diseases]. Yang YF Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):404-406. PubMed ID: 30317750 [TBL] [Abstract][Full Text] [Related]
34. Microbial dysbiosis in the gut drives systemic autoimmune diseases. Mousa WK; Chehadeh F; Husband S Front Immunol; 2022; 13():906258. PubMed ID: 36341463 [TBL] [Abstract][Full Text] [Related]
36. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis. Czaja AJ World J Gastroenterol; 2016 Nov; 22(42):9257-9278. PubMed ID: 27895415 [TBL] [Abstract][Full Text] [Related]
37. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages Zhang H; Liu M; Zhong W; Zheng Y; Li Y; Guo L; Zhang Y; Ran Y; Zhao J; Zhou L; Wang B Front Immunol; 2021; 12():624360. PubMed ID: 33841405 [TBL] [Abstract][Full Text] [Related]
38. MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets. Huang C; Xing X; Xiang X; Fan X; Men R; Ye T; Yang L Biomed Pharmacother; 2020 Oct; 130():110558. PubMed ID: 32781357 [TBL] [Abstract][Full Text] [Related]
39. [Gut microbiota and immune crosstalk in metabolic disease]. Burcelin R Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223 [TBL] [Abstract][Full Text] [Related]
40. Causal effect of autoimmune liver diseases on cancer: Meta-analyses of cohort studies and Mendelian randomization study. Gu D; Zhang M; Wang Y; Bai Y; Wang X; Deng G Liver Int; 2022 Oct; 42(10):2216-2226. PubMed ID: 35775855 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]